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Abstract 
Background:  There have been a range of quality improvement (QI) and quality assurance 
(QA) initiatives in low and middle-income countries (LMICs) to improve antiretroviral 
therapy (ART) treatment outcomes for people living with HIV (PLHIV). To date, these 
initiatives have not been systematically assessed and little is known about how effective, 
cost-effective, or sustainable these strategies are in improving clinical outcomes.  
Methods: We conducted a systematic review adhering to PRISMA guidelines (PROSPERO 
ID: CRD42017071848), searching Pubmed, MEDLINE, Embase, Web of Science, and the 
Cochrane database of controlled trials for papers reporting on the effectiveness of QI and QA 
initiatives in HIV programmes in LMICs in relation to ART uptake, care retention, 
adherence, viral load suppression, mortality, and other outcomes including cost-effectiveness 
and long-term sustainability.   
Results: 1860 articles were found, of which 29 were included.  QI approaches were 
categorised as: i) health systems approaches using QI methods; ii) QI learning networks 
including collaboratives; iii) standards-based methods that use QI tools to improve 
performance gaps; and iv) campaigns using QI methods. The greatest improvements were 
seen in ART uptake (median increase of 14.0% [IQR -9.0, 29.3]), adherence (median increase 
of 22.0% [IQR -7.0, 25.0]), and viral load suppression (median increase 26.0% [IQR -8.0, 
26.0]).   
Conclusions: QI interventions can be effective in improving clinical outcomes; however, 
there was significant variability, making it challenging to identify which  aspects of 
interventions lead to clinical improvements. Standardising reporting and assessment of QI 
initiatives is needed, supported by national quality policies and directorates, and robust 
research.   
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Introduction  
Considerable strides have been made in the scale-up of antiretroviral therapy (ART) in low- 
and middle-income countries (LMICs). By the end of 2017, 21.7 million people living with 
HIV (PLHIV) were receiving ART, with a reported fall of 48% in AIDS-related deaths since 
a peak in 2005.1,2  However, only 75% of the estimated 36.7 million PLHIV globally know 
their status, 59% were receiving ART, and 47% were virologically suppressed. In LMICs 
with the highest burden of HIV, coordinated action is urgently needed to achieve targets so 
90% of all people living with HIV know their status, 90% of those diagnosed as HIV positive 
start ART, and 90% of all people receiving ART have durable viral suppression.3  
There is increasing recognition of gaps along the cascade of care, and  the need to strengthen 
the quality of service delivery.45  Various quality improvement (QI) and quality assurance 
(QA) strategies have been implemented in ART programmes.67 Many definitions of QI exist 
in the literature. The recently published WHO National Quality and Policy Strategy Manual 
(http://apps.who.int/iris/bitstream/handle/10665/272357/9789241565561-eng.pdf?ua=1) 
defines QI as “a change in process in a health-care system, service, or supplier for the 
purposes of increasing the likelihood of optimal clinical quality of care measured by positive 
health outcomes for individuals and populations.”8 For this review, we consulted with the 
Quality of Clinical HIV Care Technical Working Group (see Acknowledgments) to generate 
a narrower definition (Figure 1): “a method of improving programme quality using standard 
QI methodologies involving systems analysis, process investigation and analysis of 
results/indicators, developing solutions by teams, testing and measuring effects of changes, 
and implementing and following up improvement.” QA is defined as: “a process of external 
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measurement of performance against standards and expectation that action will be taken to 
improve performance” (Figure 1).  
Across the global literature on QI initiatives globally, there is a high risk of bias, with studies 
predominantly from high-income countries, or not specifically focused on HIV treatment 
programmes.9 Furthermore, the evidence-base is limited by a lack of systematic or robust 
examination of evidence on the effectiveness of initiatives to improve quality in the delivery 
of ART programmes.  As a result, there is a lack of consensus on effective, cost-effective, or 
sustainable approaches.  
We undertook a systematic review to identify and synthesise evidence-base on the cost-
effectiveness,  acceptability, impact of QI and QA initiatives on key clinical outcomes in 
ART programmes in LMICs, and wider indicators.  
 
Methods  
This systematic review adhered to the Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA) guidelines,10 and the protocol published on the PROSPERO 
database (CRD42017071848; 
https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=71848). 
Inclusion and exclusion criteria 
We included randomised controlled trials, observational studies, and grey literature reporting 
on the effectiveness of QI and QA initiatives implemented in ART programmes in low- and 
middle-income countries (LMICs) as defined by World Bank classification.11  
We considered evidence of effectiveness for pre-defined outcomes including: 
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• Key clinical outcomes: ART uptake, care retention, adherence, viral load suppression 
and mortality 
• Other outcomes: screening, identification, and treatment of incident opportunistic 
infections, process indicators such as CD4/VL testing, acceptability to patients and/or 
service providers, prevention of mother to child HIV transmission  
• Cost-effectiveness 
• Wider impact (e.g. long-term sustainability)  
There were no restrictions on language. Research was excluded if it was conducted in high-
income countries, data for key outcomes were not present, or the main focus of the 
intervention was task-shifting, which is not considered a QI or QA intervention for the 
purposes of this review. In addition, papers only reporting on specific types of clinical 
care/interventions (e.g. prevention of mother to child HIV transmission) were not included.  
These studies represent a substantial and important literature, and merit separate reviews 
tailored to the specific methodologies and outcomes relevant to these distinct areas. Training, 
clinical mentoring, and supportive supervision, without the precise improvement actions 
defined as part of QI, were not included, as the focus was on quality improvement methods 
rather than the specific components of interventions; in addition, we note that supportive 
supervision and mentorship has its own literature, as part of broader quality assurance efforts. 
These decisions were made in consultation with the Quality of Clinical HIV Care Technical 
Working Group. 
Search strategy 
We searched the databases Pubmed, MEDLINE, Embase, Web of Science, and the Cochrane 
database of controlled trials from inception to 24/10/17.  We used a Boolean search strategy 
with keywords relevant to quality improvement, quality assurance, and HIV, identified from 
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relevant research, previous related systematic reviews, and consultation with the World 
Health Organization and Quality of Clinical HIV Care Technical Working Group (see 
Supplementary information for full search strategy). Grey literature was obtained through a 
hand-search of web search engines, related websites, and submission by key experts in the 
Quality of Clinical HIV Care Technical Working Group. These experts were also formally 
invited to submit grey literature (conference abstracts, unpublished reports, presentations etc) 
relating to QI in ART programmes in LMICs. The bibliographies of included papers were 
cross-referenced, and key experts consulted, to identify additional research.  
Data extraction and analysis 
Title and abstract screening was carried out by three reviewers (KR, LBN, SH). Subsequent 
full-text screening was carried out by two reviewers (SH, KR). Discrepancies were resolved 
through discussion with a third reviewer. Screening was facilitated by the web-based 
application Rayyan.12 
Data were extracted by two reviewers (KR, SH) using a piloted form on pre-defined 
outcomes determined by the study team through consultation with experts in the field.  The 
outcomes included: ART uptake, retention in care, adherence, viral load suppression, 
mortality, and other wider outcomes (opportunistic infections, acceptability to patients and 
service providers, process indicators, cost-effectiveness, and long-term sustainability).  
Quality and risk of bias were assessed by two reviewers (KB, LN) using a piloted critical 
appraisal tool which included indicators from the Joanna Briggs and Newcastle-Ottawa scales 
as relevant for the diverse study types.13,14 The average quality score was 69.1%.  Quality 
scores were divided into tertiles, categorising papers in relation to whether they were scored 
in the low (22.7% – 59.1%), medium (63.6% – 72.7%), or high (77.3% - 100%) third of 
papers.  Whilst study quality was assessed in order to indicate methodological rigour and 
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clarity and transparency in reporting, studies were not excluded on the basis of quality in 
order to strengthen the transparency of the review and comprehensively report on all 
available evidence, including both primary peer-reviewed research and the grey literature. 
All included studies were categorised in relation to methodological approaches agreed in 
collaboration with the identified panel of experts (Figure 1):   health systems approaches 
using quality improvement methods, standards-based methods that use QI tools to improve 
performance gaps, campaigns that use QI methods, and QI learning networks including 
collaboratives. 
Summary analyses were carried out in Microsoft Excel and Stata 15 to show the distribution 
of percent increase reported for each outcome by study, and to calculate the mean and median 
increase in the percentage of patients with each clinical outcome to provide an indication of 
the reported impact of QI interventions across the available evidence base.  We also 
compared the median increase in ART uptake by methodological approach and country 
setting, and in programmes focused on the prevention of mother to child transmission 
(PMTCT) compared to the general patient population. Where relevant data were not reported 
for the pre-defined outcomes, papers were not included in the syntheses. 
Role of the funding source  
The funders of the study had no role in study design, data collection, data analysis, data 
interpretation, writing of the report, or the decision to submit the paper for publication. All 
authors had full access to all data, and responsibility for the decision to submit for 
publication.  
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Results  
Overview of included literature 
1860 records were identified in the database searches, with 1073 publications being subject to 
title and abstract screening after removing duplicates. 101 publications were carried forward 
for full-text screening, in addition to 34 grey literature records. Of the 135 papers included in 
the full-text screening, 29 were included in the review (see Figure 2), including 14 were peer-
reviewed15,16,25–28,17–24 and 15 grey literature articles (Supplementary Table 1).29,30,39–43,31–38 
There was signicant variation in the quality of included studies (reported in Supplementary 
Table 1), with limited detail in relation to measures, outcomes or definitions used, 
observational designs across a majority of studies, and a lack of data to isolate the effects of 
interventions. 
Many initiatives involved a multifaceted package of interventions. No studies were identified 
that reported solely on QA, therefore our results present no data on QA initiatives. There are 
a range of quality initiatives being evaluated in LMICs (Standards-based Management and 
Recognition, HIVQUAL/HEALTHQUAL [Note HIVQUAL changed its name to 
HEALTHQUAL], Breakthrough Series Collaborative, ASSIST), as well as multiple other 
approaches (quality collaboratives, Performance management-quality improvement, 
mentorship and training without specific QI component, amongst others).  
We grouped approaches into four main categories with support from experts in the Quality of 
Clinical HIV Care Technical Working Group (Figure 1): health systems approaches using 
quality improvement methods (n = 20),21,22,34–43,24–26,29–33 Standards-based methods that use 
QI tools to improve performance gaps (n = 2),17,23 Campaigns that use QI methods (n =1),28 
and QI Learning Networks including collaboratives (n = 6).15,16,18–20,27 Initiatives were carried 
out in 13 LMICs, including South Africa,15,19,20,28 Vietnam,16,35 Zambia,17,23 Nigeria,18,27 
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Uganda,21,22,31,36,40 Mozambique,21,22 Namibia,21,22,29,34,42,43 Haiti,21,22,24,32,36,41 Thailand,25,26 
Nicaragua,33 Kenya,38 Tanzania,37 and Guyana,34,39 (Figure 3). Across the studies, 
improvements were reported for ART uptake (n=17), ART adherence (n=10), CD4 testing 
(n=6), retention (n=5), and cost (n=1) (Figure 4).   
Overall impact of QI approaches 
There was significant variation across the evidence regarding the influence of QI initiatives 
on clinical outcomes (Figure 5). The greatest improvement was seen in ART uptake (median 
increase of 14.0% (IQR -9.0, 29.3) of patients across sites), ART adherence (median increase 
of 22.0% (IQR -7.0, 25.0)), and viral load suppression (median increase 26.0% (IQR -8.0, 
26.0)) (see Supplementary Table 1). 
These outcomes should be considered in the context of other initiatives and national policy 
and programme changes that may have targeted ART uptake and adherence, and viral load 
suppression at the same time.  Improvements may also be partly attributed to inclusion of 
programmes focused on the prevention of mother-to-child transmission (PMTCT; 
Supplementary Table 1). We carried out a sensitivity analysis to examine the increase in ART 
uptake in pregnant women compared to the general patient population across the evidence, 
identifying that the median percentage increase in patients initiating ART in programmes 
focused on PMTCT was 19.0% (IQR 13.5, 40.5) compared 13.0% (IQR 4.5, 29.3) for 
programmes directed at the general population (Table 1), though this was not statistically 
significant. 
There was also significant variation in the effectiveness of QI interventions across initiatives 
implemented in different country settings. The highest median percentage improvement in 
ART uptake was seen in Vietnam (29.0%, IQR 29.0, 29.5), followed by Haiti (25.0%, IQR 
13.0, 37.0), however there were limited data for other countries, and variability in the length 
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of follow up, making it challenging to make meaningful cross-country comparisons (Table 2). 
For example, three studies looking to improve ART uptake had follow-up periods of 8-,35 12-
,
31
 and 24-months.32   
Effectiveness by QI methodological approach 
(i) Health systems approaches using QI methods 
20 studies (5 published; 15 grey literature) were categorised as health systems approaches 
using QI methods (e.g. including systems analysis, process investigation and analysis of 
results/indicators, developing solutions by teams, testing and measuring effects of changes, 
and implementing and following up improvement) (Figure 1). 14 studies reported outcomes 
related to ART uptake, generally showing a positive impact. In one study, the number of 
eligible children taking up treatment rose from 12 to 25%,32 whilst ART uptake rose from 61 
to 90% in another health systems intervention.35 Even in a previously well performing 
setting, ART uptake rose from 98 to 100% after the introduction of the intervention.25 
However, there were also two examples of a decline in ART uptake.  In one such case, uptake 
fell from 82 to 76% over a 12-month period,31 whilst in another, CD4 testing for subsequent 
ART treatment in individuals with CD4 cell counts < 200/µl dropped from 100 to 90% of 
eligible individuals.26 Overall, the median percentage increase in patients initiated on ART in 
programmes utilising this methodological approach was 13.0% (IQR 5.5, 34.3), with a range 
of -13.0% (decrease) to 59.0% (Table 1).  
Among papers reporting health system approaches using QI methods, there were also nine 
studies reporting ART adherence (2 published; 7 grey literature), and five studies reporting 
on retention. Six of the nine studies reporting adherence outcomes showed improved 
adherence documentation and recording procedures, as opposed to being related directly to 
the level of adherence seen in individuals on treatment. One study reported that paediatric 
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adherence rose from 43 to 81%,36 whilst a multi-centre study documented improvements in 
adherence from 90 to 97% in Namibia, 63 to 85% in Uganda, 66 to 97% in Mozambique, 29 
to 83% in Haiti, and 56 to 80% in Guyana.39 One study reported a decrease in adherence from 
82 to 76%;  however, this finding may be due to an associated improvement in 
documentation procedures and adherence assessment, which increased from 81 to 92%.31 
Retention was also suggested to slightly increase across the studies (median increase 3.0%, 
IQR 3.0, 3.0; range 3.0 – 25.0).  
Health systems approaches utilising QI methods were also associated with positive impacts 
on process indicators.  CD4 testing rates over 6 months improved from 43  to 78% in one 
setting,35 and from 10.8 to 20.5% when testing individuals upon enrolment and after 6 
months of follow up.41 However, there were not always substantial gains or improvements.44 
Prophylaxis for opportunistic infections also increased. One study reported an increase from 
12 to 95% of children receiving cotrimoxazole prophylaxis,43 whilst another reported that 
prophylaxis peaked during the intervention at 84.8% of eligible individuals receiving 
treatment.41 Tuberculosis screening also increased across all reports, with one example citing 
an increase from 24 to 99%.26  
(ii) QI learning networks across multiple sites (including collaboratives) 
Six peer-reviewed papers reported on QI learning networks (including collaboratives), which 
included coaching and mentoring of healthcare staff, alongside peer exchange to address 
performance gaps. One model adopted was the Breakthrough Series (BTS) collaborative,15 
which brings facility teams together to learn QI methods, identify performance gaps, and plan 
implementation interventions, with follow up visits from quality mentors to coach teams on 
using QI methods and maintain momentum for improvement.  Four studies reported on ART 
uptake outcomes, all of which showed improvements. Overall, the median increase in ART 
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uptake was 22.0% (IQR 12.8, 29.8) (Table 1).  One study reported a district level increased 
uptake of 62 to 91% over 30 days.16 In another setting, monthly ART initiation rose 185.5% 
following initiation of the intervention, from 179 initiations per month to 511.19 ART 
adherence and retention were only reported in one study each. The study which included 
adherence outcomes reported improvements in documentation of adherence support and 
adherence assessment procedures, and it was not clear if there was an impact on patient 
adherence. In this study, documentation improved from 83 to 99% at the provincial level, and 
from 54 to 97% at the district level.16 In terms of ART retention, the one reporting study 
found no impact associated with the intervention, with no statistically significant difference 
in retention of post-partum women after 6-months in the intervention and control arms.18 
The effects of QI interventions on process indicators, opportunistic infection and TB 
screening were sparsely reported. The studies reporting on process indicators indicated an 
improvement associated with the intervention.  CD4 testing in the previous 6-months 
increased from 80 to 94% at the provincial level, and from 72 to 74% at the district level in 
one setting,16 and rates of early infant testing at 4-6 weeks increased in intervention sites from 
25.3% to 48.8% in another study.18 Data quality was reported to have improved in another 
setting.27 Cotrimoxazole prophylaxis prescription to combat opportunistic infections in 
eligible individuals increased in one study from 31 to 99% at the provincial level, and from 
75 to 83% at the district level, whilst TB screening in this same study also increased from 15 
to 100% at the provincial level and from 18 to 79% at the district level.16 
One study further looked at the acceptability of the intervention to healthcare workers and 
patients.  However, despite enthusiastic participation in the programme by healthcare 
workers, there was no measurable increase in patient satisfaction.27 
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(iii) Standards-based methods that use QI tools to improve performance gaps 
The two citations which utilised standard-based methods only reported on acceptability of the 
intervention (2 published, 0 grey literature).17,23 The studies initially sought to define 
performance criteria relevant to the context, before utilising outside support to measure pre-
existing performance gaps (in relation to the new standards), which are subsequently 
addressed and re-assessed. In both studies, the authors indicated that healthcare worker 
perceptions of their work environment were positively impacted by the intervention, whilst 
they declined in comparison sites. Standards-based methods also increased ART readiness 
scores, and provider performance related to ART and PMTCT at the intervention sites versus 
comparison sites.17   
(iv) Campaigns that use QI methods 
Only one study reported a QI campaign among health workers (Figure 1) in two districts in 
KwaZulu-Natal, South Africa, between 2009 and 2010, and was included as a separate 
category upon consultation with the expert group.28 This study reported on outcomes related 
to ART uptake among HIV-infected pregnant women and cost, finding that monthly referrals 
for ART rose from 798.7 (95% CI: 69-89) individuals to 188(95% CI: 167-209) in the 
intervention district , and monthly ART initiation concurrently rose from 21 (95% CI: 2-40) 
individuals to 124 (95% CI: 108-140), compared with  much smaller increases in the control 
district (91 to 99 ART referrals and 39 to 55 initiations per month). In terms of cost, there 
was no formal analysis, however the authors state that they believed the interventions could 
be rapidly implemented with a low incremental cost, as no new personnel were added to the 
existing health system.  
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Discussion 
This is the first systematic review to explore the evidence-base on the effectiveness of 
interventions to improve quality in ART programmes in LMICs, and to define and categorise 
methodological approaches being implemented in these settings. The review suggests that QI 
initiatives at site level, applied at multi-site learning collaboratives, and as part of a 
campaign, were associated with increased ART uptake and ART adherence across sites. 
However, there was variability in the effect across studies and approaches. Whilst the 
findings point to the potential effectiveness of QI interventions to improve quality, we should 
interpret the results with caution given the limitations of the study designs; i.e. lack of 
comparators or the contribution of other initiatives.  This points to the need for more rigorous 
evaluation methods to assess the impact of quality improvement interventions, and innovative 
approaches to assessing quality in public health initiatives more broadly. It is also important 
to be aware of a bias towards publication of positive results. 
The effect of other programme factors is noted in some cases, both in rapid improvement of 
clinical outcomes, and in an an apparent worsening of outcomes in some cases, which could 
influence the interpretation of QI studies. For example, in Uganda, ART uptake decreased 
from 82 to 76% over 12 months,31 and in Thailand, CD4 testing coverage dropped from 
100% to 90%.26 As both of these studies were supported by authors of this manuscript, 
further information was obtained from the programme reports, and it is reported that in 
subsequent years, ART coverage increased, while the number of patients enrolled in care 
increased dramatically over that time period.  As well, in Thailand, the drop in CD4 
monitoring may have been related to a rapid expansion in the program from 12 hospitals in 
2002 to 64 in 2006, thus highlighting the impact of other programme factors. The 
heterogeneity across QI initiatives makes it challenging to discern the relative benefit of 
specific QI approaches. Both increases and decreases in the research need to be 
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contextualised in relation to factors such as methodological variations, socio-economic 
conditions, changes in health expenditure, and other possible factors such as stockouts, and 
documentation challenges. 
Our findings concur with a recent systematic review exploring one QI approach 
(collaboratives ) mostly being evaluated in high-income countries, which reported that the 
evidence for effectiveness of initiatives that use QI collaboratives is positive, but that the 
effects cannot be predicted with great certainty with limited evidence of effectiveness, cost-
effectiveness, and sustainability.7   
Many QI initiatives involve a complex multifaceted package of interventions. For example, 
HEALTHQUAL is a public health model for capacity building and can involve multiple 
interventions as part of the effort to improve health systems.  Studies may also report 
outcomes on initiatives involving QI and other capacity-building initiatives, and also adapt 
established QI models to local use.16 This means that it is often not straightforward to identify 
which particular aspect of a QI initiative, has led to improvements. A strength of QI 
initiatives is that they target multiple aspects of the health system which support clinical 
processes. However, these changes are often introduced simultaneously making it challenging 
to identify which factors contribute to improvements. However, it is hypothesised that this 
more ‘holistic’ approach is required for successful programmes, suggesting that  QI 
initiatives and methods should be judged on the overall effectiveness of the programme, 
rather than attempting to elucidate which specific components are most integral to the 
benefits observed.45  
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Strengths and limitations 
The review utilised a rigorous approach, aligning with PRISMA guidelines, and was 
registered prospectively in PROSPERO. The results are driven by a comprehensive search 
strategy, which includes five databases and grey literature. The assessment of key clinical 
outcomes alongside other wider effects allowed a broad examination of evidence of 
effectiveness, enabling a robust synthesis to evaluate and inform QI initiatives. A formal 
meta-analysis was not deemed appropriate given the heterogeneity in QI approaches, study 
methods, and reporting.  However, studies consistently reported percent increases in the pre-
defined outcomes, allowing such data to be combined and summarised to provide an 
indication of the reported impact of QI interventions across the available evidence base.  
Quality scores for included papers ranged from 22.7% to 100%, with a third of papers scoring 
below 60%, which were categorised as low quality.  The significant variation in the quality of 
study designs as well as reported outcomes and their definitions highlights the need to 
improve methodological rigour in evaluation and research in this area.  The evidence base 
would be strengthened by efforts to adopt emerging QI evaluation designs.46 The decision to 
retain papers and not exclude on the basis of quality was essential in order to demonstrate the 
range of quality across the available evidence base, and the need to strengthen study quality, 
benefitting the transparency and impact of this review.   
There was limited reporting of QI initiatives in both the published and grey literature, with 
few peer-reviewed studies of the effectiveness of QI/QA initiatives, or publicly available 
evaluations. For many organisations, QI is part of standard technical assistance for countries, 
and reports of QI work may be disseminated only internally within the support organisations 
or funding bodies.  
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Another key limitation is that improvements may not be solely attributed to the QI 
interventions, but also wider initiatives targeting HIV programmes or healthcare systems, or 
improvements in documentation and data recording procedures. For example, changes in 
national policies to shift CD4 eligibility criteria or HIV testing campaign or expansion of 
sites/task shifting/decentralisation effort would improve certain outcomes unrelated to the 
specific QI efforts.  Future research should aim to address these concerns, and where 
interventions are implemented, these wider contextual factors should be acknowledged 
through the adoption of implementation science frameworks.  
The WHO recently published recommendations for Standard Programme Reporting 
standards,47 which could be enhanced with practitioners agreeing on a common set of clinical 
and health system outcomes.  It has also been proposed that the design and evaluation of such 
programmes should be mutually informing for both improvers and evaluators. The 
Framework for Learning about Improvement and the Evaluation Continuum, for example, 
provides a structure to improve the design, implementation, and evaluation of improvement 
programmes.  This could enable both the generation of more robust and generalisable data, 
and improve understandings of the mechanisms contributing to improvement, and how to 
scale-up improvement efforts.48  
Evaluation of programmatic quality could be further enhanced through improved reporting 
mechanisms to assess implementation, which could be based on commonly agreed core 
components for QI programmes.49 Standardised quality scores based on national guidelines 
for care recommendations have been developed in similar contexts assessing adherence to 
such guidelines, and have been shown to be associated with decreased mortality in these 
settings.50 The implementation of such procedures across all settings would enable a fuller 
comparison of QI programmes, alongside their respective standards of quality both pre- and 
post- intervention.49 
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The ability to assess the impact of QI interventions on clinical outcomes, or determine which 
specific approaches result in the greatest improvements is also limited by observational study 
designs. However, a key strength of the approaches across the included studies is the 
development and implementation of interventions in the community context at which they are 
aimed, which is likely to increase the success of QI initiatives.45  
Most of the included studies had externally funded implementing partners providing staff to 
support data collection, implementation, and evaluation. This reliance on external technical 
support raises a question about the sustainability and scalability of these interventions. Many 
interventions included participation from management and frontline teams of the local health 
system, but did not demonstrate the ability to undertake QI efforts using local data systems, 
or sustainability or scalability beyond the life of the project.  
The use of external or parallel data systems also circumvented the poor quality of routinely 
collected data  –  a major obstacle to the implementation, scale up, sustainability, and 
evaluation of QI interventions. Many of the studies reported in the review used data that was 
collected independently of the local routine data reporting systems, and the future 
performance of those initiatives may be dependent on continued support. There are some 
examples of large scale QI programming that used routine data systems, showing that is 
possible to improve local data systems to the point where they can be used for QI approaches. 
While one of the aims of this review was to assess sustainability, the identified literature did 
not specifically address this question so no data are presented. 
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Conclusions and further research 
Our findings support the effectiveness of QI in ART programmes, with the greatest 
improvement in clinical outcomes seen in ART uptake, adherence, and viral load 
suppression, and in programmes focused on PMTCT. Though the evidence suggests QI 
initiatives are associated with improved clinical outcomes, there was significant 
heterogeneity across approaches, settings, and reporting, making it challenging to identify 
best practices and to understand what specific aspects of these interventions lead to 
significant and sustainable clinical improvements in an LMIC context. Furthermore, there 
was very limited evidence on the cost-effectiveness of these interventions, and a need for 
formal economic analyses to determine the cost implications of QI initiatives.   
The findings point to the need to better utilise standard evaluation designs and reporting 
methods.5147 Whilst programmatic quality reporting focusing on the implementation of 
interventions against established guidelines would enhance our ability to compare the 
effectiveness of interventions across diverse settings, it could also be tailored the specific 
context in which programmes are being delivered, for example primary healthcare sites as 
opposed to specialty care.5,49,50,52  
A further key consideration for practice is the need to embed QI initiatives within national 
efforts to improve health systems. Most of the studies in this review were supported or 
conducted by implementing partners with external funding, using external data collection and 
analysis systems. The question remains what approaches will be needed to support the 
capacity of health systems in LMICs to undertake these approaches through their existing 
quality management infrastructure without a need for external partners and funding.  In a 
related field, the WHO-led Network for Improving Quality of Care for Maternal Newborn 
and Child Health Care  is driving the approach of moving care away from NGO-led, 
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fragmented and often unsustainable individual quality improvement projects toward country-
led initiatives.53 WHO is also providing guidance to governments on how to design and 
organise national QI programming through development of their National Quality Policy and 
Strategies, an approach which supports the use of QI in ART programmes to reach 90-90-90 
targets within the context of Universal Health Coverage54,55 across HIV programmes 
globally.53   
Research is needed to evaluate the effectiveness, cost-effectiveness, and long-term 
sustainability of quality improvement interventions, and identify which elements contribute 
to improved clinical outcomes in LMICs. This will  support efforts to achieve the 90-90-90 
goals,56 and aligns with the recent Lancet Global Health Commission on high-quality health 
in the SDG Era.57 Ultimately, evidence-based QI methods must be integrated into broader 
efforts to ensure the delivery of high-quality care in low resource settings, within the context 
of the WHO Framework on integrated people-centred health services.58,59 
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Table 1. Changes in ART uptake by population and QI/QA approach 
 Population QI approach 
 Maternity General Health system approach using QI methods QI learning network 
Mean % (SD) 28.0 (17.6) 19.0 (20.0) 20.0 (21.3) 23.0 (12.0) 
Median % (range) 19.0 (12.0,  56.0) 13.0 (-13.0, 59.0) 13.0 (-13.0, 59.0) 22.0 (12.0, 41.0) 
Interquartile range (IQR) 25%, 
75% 
13.5, 40.5 4.5,  29.3 5.5, 34.3 12.8, 29.8 
 
Table 2. Changes in ART uptake by country of study 
 South 
Africa 
Vietnam Haiti Thailand Namibia Uganda Mozambique Guyana 
Mean % (SD) 23.0 (14.1) 29.0 (0.6) 26.0 (14.5) 2.0 22.0 923.4) 18.0 (28.4) -13.0 5.0 
Median % (range) 14.0 (12.0,  
41.0) 
29.0 (29.0 - 
30.0) 
25.0 (13.0,  
40.0) 
2.0 15.0 (3.0, 
56.0) 
9.5 (-6.0, 
59.0) 
-13.0 5.0 
Interquartile 
range (IQR) 25%, 
75% 
12.0, 21.5 29.0, 29.5 13.0, 37.0 -- 9.0, 28.3 3.75, 23.8 -- -- 
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Figure 1. Definitions and categorisation of QI/QA interventions used for this systematic review. 
Definitions: 
  
A quality improvement intervention: a method of improving programme quality using standard QI methodologies involving systems analysis, process investigation and 
analysis of results/indicators, developing solutions by teams, testing and measuring effects of changes, and implementing and following up improvement  
  
A quality assurance intervention: a process of external measurement of performance against standards and expectation that action will be taken to improve 
performance 
 
Methodological categorisations of reported QI initiatives: 
 
1. Health systems approaches that use QI methods: A method of 
improving programme quality involving process investigation and analysis 
of results/indicators, developing solutions by teams, testing and measuring 
effects of changes, and implementing and following up improvement. 
2. Standards-based methods that use QA and QI tools to improve performance gaps: A 
model which combines assessment of performance through external measurement of a 
core set of standards (QA), together with a QI process to implement of best practices, 
follow up measurement of progress and rewarding achievement through social/peer 
recognition mechanisms. 
 
 
 
3. QI learning networks: A structured approach that uses QI methods to 
promote improvement activities and successful improvement strategies 
across multiple networked facilities in a health system. Network structure 
offers face to face opportunities and a virtual platform to build 
improvement skills, share improvement and technical knowledge, monitor 
performance, and spread improvement principles. 
4. QI campaigns: An intensive improvement approach to improve care in a particular 
clinical area and designed to influence change in a large geopolitical area (region or  an 
entire country). Campaigns are designed to mobilise large groups of providers – 
hundreds or thousands – to focus on the selected area of care that has been identified as 
an urgent priority. Senior officials and opinion leaders visibly champion the cause of the 
campaign and facilities and communities are engaged through public programmes and 
the media. QI methods are used to adapt well developed implementation strategies to 
local context.  
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Figure 2. PRISMA flow diagram 
 
 
 
Records identified through 
database searching 
(n = 1860) 
Title and abstract 
screening 
(n = 1073) 
Reasons for exclusion: 
• High-income setting (n=6) 
• Not a defined QI intervention 
(n=49) 
• No ART related outcomes data 
(n=35) 
• Not primary research (n=2) 
• Duplicates (n=14) 
 
Full-text articles assessed 
for eligibility: 
Primary research (n = 101) 
Grey literature (n=34) 
Citations included in 
review 
(n =  29)  
Primary research (n=14) 
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Figure 3. Proportion of QI initiatives reported in the included literature. 
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Figure 4. Proportion of included studies reporting improvements in key outcomes 
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Figure 5. Percentage increase in outcomes across QI/QA initiatives 
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